Here is what you need to know on Wednesday, September 16:
Majors traded choppy this Tuesday, with the dollar recovering during US trading hours some of the ground given earlier in the day. Most pairs remained within familiar levels, as investors remain focused on first-tier events, starting with the US Federal Reserve this Wednesday.
The EUR/USD pair peaked at 1.1900, underpinned by an upbeat ZEW survey, but closed the day in its comfort zone around 1.1850.
The Pound was able to retain gains, despite mounting Brexit tensions, after the Commons passed the Internal Market Bill. UK employment data were generally positive, providing support to the Sterling.
The Japanese yen appreciated further, despite the market’s mood was mostly positive. USD/JPY fell to 105.29 before bouncing some but is still at risk of falling.
The WTO ruled that US tariffs on China violate trade rules. The market ignored the headline, but may hint trouble ahead and an escalation of US-China tensions.
Crude oil prices edged higher, underpinned at the beginning of the day by a weaker dollar, and later by resurgent equities demand. WTI moved above $38.00 a barrel despite OPEC’s gloomy demand perspective.
Gold has managed to post a higher high for the week, reaching 1,972 before trimming intraday gains. It continues to trade in its comfort zone around $1,950 a troy ounce.
US Treasury yields ticked higher as investors asset coronavirus developments. Wall Street managed to advance but closed unevenly as the DJIA turned red ahead of the close.
The WHO has warned that Europe should be expecting an increase in the death rate in October and November. The number of cases has risen sharply in recent weeks, especially in Spain and France. Meanwhile, in the US, the death toll is about to reach the 200,000 threshold.
Also, the University of Pittsburgh School of Medicine scientists have isolated the smallest biological molecule to date that completely and specifically neutralizes the SARS-CoV-2 virus, which is the cause of COVID-19. This antibody component, known as Ab8, has potential use as a therapeutic and prophylactic against SARS-CoV-2.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
Follow us on Telegram
Stay updated of all the news
EUR/USD stays below 1.0700 as USD gathers strength
EUR/USD continues to trade in negative territory below 1.0700 on Wednesday. Higher-than-expected increase in US JOLTS Job Openings for April provides a boost to the US Dollar and weighs on the pair as investors keep a close eye on US debt-limit news.
GBP/USD struggles to recover above 1.2400
GBP/USD has lost its traction and declined below 1.2400 after having climbed above that level earlier in the day. The pair struggles to gather recovery momentum as the US Dollar holds its ground after strong employment data. Markets await House vote on debt-limit bill.
Gold extends daily rebound beyond $1,970
Gold price has gained traction and advanced above $1,970 in the second half of the day on Wednesday. The benchmark 10-year US Treasury bond yield stays in negative territory and allows XAU/USD to keep its footing. Market mood remains cautious ahead of the debt-ceiling vote.
Ethereum holders pull $1 billion in ETH off exchanges hinting retail-led rally
Ethereum holdings in exchange wallets declined by $1.04 billion between May 8 and May 31. Interestingly, while large wallet investors have shed their Ether holdings, the altcoin got redistributed to addresses with less than 1 ETH.
C3.ai Stock News: After 33% rally, AI shares backtrack ahead of earnings
C3.ai (AI) stock slipped 7.6% to $41.62 in Wednesday’s premarket ahead of quarterly earnings expected after the close. This may just be traders taking profits after Tuesday’s 33.4% surge in the AI stock price.